Key result
In 155 patients followed for an average of 14 months, cloth-covered Starr-Edwards prostheses had a high incidence of early fatal thrombo-embolus after mitral valve replacement.
Why the study?
What are the thrombo-embolic complications associated with cloth-covered Starr-Edwards prostheses No. 2300 aortic and No. 6300 mitral?
Cohort (n=155)
What are the thrombo-embolic complications associated with cloth-covered Starr-Edwards prostheses No. 2300 aortic and No. 6300 mitral?
Cloth-covered Starr-Edwards prostheses are associated with significant thrombo-embolic risks that vary by valve position, complicated by hazardous anticoagulant control.
High early fatal thromboembolic risk after mitral replacement with cloth-covered Starr-Edwards; hypothesis-generating in observational data and should not yet change practice.
The thrombo-embolic complications of the cloth-covered Starr-Edwards prostheses No. 2300 aortic and No. 6300 mitral followed for an average of 14 months in 155 patients are reviewed. There was a high incidence of early fatal and disabling thrombo-embolus in patients having mitral valve replacement. Late emboli were more common after aortic valve replacement. Anticoagulant control was unsatisfactory and not without hazards.
No takes yet. Share an insight, caveat, or question.
Cleland et al. (1973) conducted a cohort in Aortic or mitral valve replacement (n=155). Cloth-covered Starr-Edwards prostheses No. 2300 aortic and No. 6300 mitral was evaluated on Thrombo-embolic complications. In 155 patients followed for an average of 14 months, cloth-covered Starr-Edwards prostheses had a high incidence of early fatal thrombo-embolus after mitral valve replacement.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: